Jacobs Levy Equity Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,440
Closed -$173K 1113
2018
Q2
$173K Buy
+5,440
New +$173K ﹤0.01% 965